PRUDENTIAL FINANCIAL INC
For the period ended Sep 30, 2025. Filed Oct 30, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2025 · Filed Oct 30, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
18. Earnings Per Share
- EARNINGS PER SHARE
A reconciliation of the numerators and denominators of the basic and diluted per share computations of Common Stock based on the consolidated earnings of Prudential Financial for the periods indicated is as follows:
| Three Months Ended September 30, | ||||||||
|---|---|---|---|---|---|---|---|---|
| 2025 · 2024 | ||||||||
| Income · WeightedAverageShares · Per ShareAmount · Income · WeightedAverageShares · Per ShareAmount | ||||||||
| (in millions, except per share amounts) | ||||||||
| Basic earnings per share | ||||||||
| Net income (loss) | $1,483 | $451 | ||||||
| Less: Income (loss) attributable to noncontrolling interests and redeemable noncontrolling interests | 52 | 3 | ||||||
| Less: Dividends and undistributed earnings allocated to participating unvested share-based payment awards | 15 | 5 | ||||||
| Net income (loss) attributable to Prudential Financial available to holders of Common Stock | $1,416 | 351.1 | $4.03 | $443 | 356.9 | $1.24 | ||
| Effect of dilutive securities and compensation programs | ||||||||
| Add: Dividends and undistributed earnings allocated to participating unvested share-based payment awards—Basic | $15 | $5 | ||||||
| Less: Dividends and undistributed earnings allocated to participating unvested share-based payment awards—Diluted | 15 | 5 | ||||||
| Stock options | 0.0 | 0.2 | ||||||
| Deferred and long-term compensation programs | 1.9 | 1.6 | ||||||
| Diluted earnings per share | ||||||||
| Net income (loss) attributable to Prudential Financial available to holders of Common Stock | $1,416 | 353.0 | $4.01 | $443 | 358.7 | $1.24 | ||
| Nine Months Ended September 30, | ||||||||
|---|---|---|---|---|---|---|---|---|
| 2025 · 2024 | ||||||||
| Income · WeightedAverageShares · Per ShareAmount · Income · WeightedAverageShares · Per ShareAmount | ||||||||
| (in millions, except per share amounts) | ||||||||
| Basic earnings per share | ||||||||
| Net income (loss) | $2,791 | $2,773 | ||||||
| Less: Income (loss) attributable to noncontrolling interests and redeemable noncontrolling interests | 120 | (11) | ||||||
| Less: Dividends and undistributed earnings allocated to participating unvested share-based payment awards | 31 | 33 | ||||||
| Net income (loss) attributable to Prudential Financial available to holders of Common Stock | $2,640 | 352.8 | $7.48 | $2,751 | 358.3 | $7.68 | ||
| Effect of dilutive securities and compensation programs | ||||||||
| Add: Dividends and undistributed earnings allocated to participating unvested share-based payment awards—Basic | $31 | $33 | ||||||
| Less: Dividends and undistributed earnings allocated to participating unvested share-based payment awards—Diluted | 31 | 33 | ||||||
| Stock options | 0.1 | 0.2 | ||||||
| Deferred and long-term compensation programs | 1.8 | 1.4 | ||||||
| Diluted earnings per share | ||||||||
| Net income (loss) attributable to Prudential Financial available to holders of Common Stock | $2,640 | 354.7 | $7.44 | $2,751 | 359.9 | $7.64 | ||
Unvested share-based payment awards that contain nonforfeitable rights to dividends are participating securities and included in the computation of earnings per share pursuant to the two-class method. Under this method, earnings attributable to Prudential Financial are allocated between Common Stock and the participating awards, as if the awards were a second class of stock. During periods of net income available to holders of Common Stock, the calculation of earnings per share excludes the income attributable to participating securities in the numerator and the dilutive impact of these securities from the denominator. In the event of a net loss available to holders of Common Stock, undistributed earnings are not allocated to participating securities and the denominator excludes the dilutive impact of these securities as they do not share in the losses of the Company. Undistributed earnings allocated to participating unvested share-based payment awards for the three months ended September 30, 2025 and 2024, as applicable, were based on 3.8 million and 3.9 million of such awards, respectively, and for the nine months ended September 30, 2025 and 2024, as applicable, were based on 3.9 million and 4.0 million of such awards, respectively, weighted for the period they were outstanding.
Stock options and shares related to deferred and long-term compensation programs that are considered antidilutive are excluded from the computation of diluted earnings per share. Stock options are considered antidilutive based on application of the treasury stock method or in the event of a net loss available to holders of Common Stock. Shares related to deferred and long-term compensation programs are considered antidilutive in the event of a net loss available to holders of Common Stock. For the periods indicated, the number of stock options and shares related to deferred and long-term compensation programs that were considered antidilutive and were excluded from the computation of diluted earnings per share, weighted for the portion of the period they were outstanding, are as follows:
| Three Months Ended September 30, | |||||
|---|---|---|---|---|---|
| 2025 · 2024 | |||||
| Shares · Exercise PricePer Share · Shares · Exercise PricePer Share | |||||
| (in millions, except per share amounts, based on weighted average) | |||||
| Antidilutive stock options based on application of the treasury stock method | 0.2 | $108.68 | 0.0 | N/A | |
| Antidilutive stock options due to net loss available to holders of Common Stock | 0.0 | 0.0 | |||
| Antidilutive shares based on application of the treasury stock method | 0.0 | 0.0 | |||
| Antidilutive shares due to net loss available to holders of Common Stock | 0.0 | 0.0 | |||
| Total antidilutive stock options and shares | 0.2 | 0.0 | |||
| Nine Months Ended September 30, | |||||
|---|---|---|---|---|---|
| 2025 · 2024 | |||||
| Shares · Exercise PricePer Share · Shares · Exercise PricePer Share | |||||
| (in millions, except per share amounts, based on weighted average) | |||||
| Antidilutive stock options based on application of the treasury stock method | 0.2 | $108.68 | 0.1 | $110.42 | |
| Antidilutive stock options due to net loss available to holders of Common Stock | 0.0 | 0.0 | |||
| Antidilutive shares based on application of the treasury stock method | 0.0 | 0.0 | |||
| Antidilutive shares due to net loss available to holders of Common Stock | 0.0 | 0.0 | |||
| Total antidilutive stock options and shares | 0.2 | 0.1 | |||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.